Ovifollin en es it fr

Ovifollin Brand names, Ovifollin Analogs

Ovifollin Brand Names Mixture

  • Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
  • Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)

Ovifollin Chemical_Formula


Ovifollin RX_link

No information avaliable

Ovifollin fda sheet

Ovifollin msds (material safety sheet)

Ovifollin MSDS

Ovifollin Synthesis Reference

G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)

Ovifollin Molecular Weight

270.366 g/mol

Ovifollin Melting Point

254.5-256 oC

Ovifollin H2O Solubility

3 g/100mL

Ovifollin State


Ovifollin LogP


Ovifollin Dosage Forms

Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension

Ovifollin Indication

For management of Menopausal and postmenopausal disorders

Ovifollin Pharmacology

Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.

Ovifollin Absorption


Ovifollin side effects and Toxicity

Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.

Ovifollin Patient Information

Ovifollin Organisms Affected

Humans and other mammals